(Q58680978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

An update on metabolism studies using human hepatocytes in primary culture (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

M T Donato

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

María José Gómez-Lechón

series ordinal

1

object named as

María José Gómez-Lechón

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Metabolism & Toxicology

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

837-854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18624674%20AND%20SRC:MED&resulttype=core&format=json

The pivotal role of hepatocytes in drug discovery

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Oxidizing species in the mechanism of cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cytochrome P-450 3A4: regulation and role in drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cytochrome P-450 mRNA Expression in Human Liver and Its Relationship with Enzyme Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Semi-automatic quantitative RT-PCR to measure CYP induction by drugs in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Human hepatocytes: isolation, cryopreservation and applications in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Re-expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Transcriptional regulation and expression of CYP3A4 in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Genetic polymorphisms in human drug metabolic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

The human genome project and novel aspects of cytochrome P450 research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Human variability in hepatic and renal elimination: implications for risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Drug biotransformation by human hepatocytes. In vitro/in vivo metabolism by cells from the same donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Carbamazepine: a 'blind' assessment of CVP-associated metabolism and interactions in human liver-derived in vitro systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Utility of Hepatocytes in Predicting Drug Metabolism: Comparison of Hepatic Intrinsic Clearance in Rats and Humans in Vivo and in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

An integrated approach to model hepatic drug clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Investigation of the utility of published in vitro intrinsic clearance data for prediction of in vivo clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

In vitro-in vivo extrapolation of hepatic clearance: biological tools, scaling factors, model assumptions and correct concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

The use of in vitro methods to predict in vivo pharmacokinetics and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Prediction of oral clearance from in vitro metabolic data using recombinant CYPs: comparison among well-stirred, parallel-tube, distributed and dispersion models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Structure elucidation of aplidine metabolites formed in vitro by human liver microsomes using triple quadrupole mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

A novel approach to perform metabolite screening during the quantitative LC-MS/MS analyses of in vitro metabolic stability samples using a hybrid triple-quadrupole linear ion trap mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Evaluation of time-dependent inactivation of CYP3A in cryopreserved human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

A Microassay for Measuring Cytochrome P450IA1 and Cytochrome P450IIB1 Activities in Intact Human and Rat Hepatocytes Cultured on 96-Well Plates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

CYP isoform induction screening in 96-well plates: use of 7-benzyloxy-4-trifluoromethylcoumarin as a substrate for studies with rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Prediction of CYP2C9-mediated drug-drug interactions: a comparison using data from recombinant enzymes and human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

UDP-glucuronosyltransferases and clinical drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Rifampin and rifabutin drug interactions: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Complexities of glucuronidation affecting in vitro in vivo extrapolation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

An assessment of udp-glucuronosyltransferase induction using primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Coordinate regulation of UDP-glucuronosyltransferase UGT1A6 induction by 3-methylcholanthrene and multidrug resistance protein MRP2 expression by dexamethasone in primary rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Quantitative structure-activity relationships for the prediction of relative in vitro potencies (REPs) for chloronaphthalenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Induction of cytochrome P450: assessment in an immortalized human hepatocyte cell line (Fa2N4) using a novel higher throughput cocktail assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Enzyme induction in cryopreserved human hepatocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cryopreservation of isolated human hepatocytes for transplantation: State of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cryopreservation-induced nonattachment of human hepatocytes: role of adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Transporters as a determinant of drug clearance and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cell lines: a tool for in vitro drug metabolism studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Generation of human hepatocytes by stem cell technology: definition of the hepatocyte.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Present status and perspectives of cell-based therapies for liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Fuentes alternativas de hepatocitos para la terapia celular

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Microscale culture of human liver cells for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837

A newin vitroapproach for the simultaneous determination of phase I and phase II enzymatic activities of human hepatocyte preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.4.7.837